As of January 23, 2025, Nicox S.A. (ALCOX.PA) has a market cap of $21.883 million USD. According to our data, Nicox S.A. is ranked No.8571 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $21.88 M |
8.37%
|
Dec 31, 2024 | $20.19 M |
-36.43%
|
Dec 29, 2023 | $31.76 M |
-60.54%
|
Dec 30, 2022 | $80.48 M |
-56.16%
|
Dec 31, 2021 | $0.18 B |
-41.26%
|
Dec 31, 2020 | $0.31 B |
-0.11%
|
Dec 31, 2019 | $0.31 B |
-13.07%
|
Dec 31, 2018 | $0.36 B |
-50.59%
|
Dec 29, 2017 | $0.73 B |
18.86%
|
Dec 30, 2016 | $0.61 B |
-7.06%
|
Dec 30, 2015 | $0.66 B |
-1.46%
|
Dec 31, 2014 | $0.67 B |
-22.41%
|
Dec 31, 2013 | $0.86 B |
3.05%
|
Dec 28, 2012 | $0.84 B |
129.56%
|
Dec 30, 2011 | $0.36 B |
-54.07%
|
Dec 30, 2010 | $0.79 B |
3,692.69%
|
Dec 31, 2009 | $20.94 M |
-12.96%
|
Dec 31, 2008 | $24.05 M |
-29.45%
|
Dec 31, 2007 | $34.10 M |
-51.84%
|
Dec 29, 2006 | $70.80 M |
547.03%
|
Dec 30, 2005 | $10.94 M |
-15.35%
|
Dec 31, 2004 | $12.93 M |
-98.74%
|
Dec 31, 2003 | $1.02 B |
2,257.14%
|
Dec 31, 2002 | $43.40 M |
-14.08%
|
Dec 31, 2001 | $50.50 M |
-40.32%
|
Dec 29, 2000 | $84.62 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Bausch Health
BHC
|
$2.85 B |
6.423 M
|
Canada
|
Santen Pharmaceutical
4536.T
|
$3.40 B |
-0.000 M
|
Japan
|
Alcon
ALC
|
$43.91 B |
-0.001 M
|
Switzerland
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
Market Cap | = | ALCOX.PA Stock Price | * | ALCOX.PA Shares Outstanding |
= | $0.31 | * | 69.01 M | |
= | $21.88 M |